Versigent Has Already Run, But I Still See More Upside
Versigent delivered a strong first full quarter as an independent company, with sales up 10.8 percent and adjusted EBITDA up 24.8 percent. The stock is not as cheap as it was right after the Aptiv separation, but a valuation near 5.1 times expected 2026 adjusted EBITDA still looks reasonable. Debt and weak first-half cash conversion are the two issues I am watching most closely.
Versigent Q2 Earnings Call Highlights
Versigent NYSE: VGNT reported second-quarter results marked by double-digit sales growth, higher adjusted EBITDA margins and the launch of its first quarterly dividend as the newly independent company navigates softer global vehicle production and elevated program-launch activity.
Versigent: Engineering Moat And Energy Play Make It A Buy Opportunity
Versigent is rated a buy with a $50/share target, leveraging operational improvements and sector diversification for revaluation upside. Temporary margin pressures from copper price lags are expected to subside in Q2/Q3, with EBITDA margins recovering toward a 10.7% target. VGNT's automation, supplier negotiations, and entry into battery energy storage enhance profitability and create a durable competitive moat.
Versigent: Valuation Should Re-Rate Upwards If Management Hits Guidance
I rate Versigent (VGNT) a buy, as the market undervalues its scale, embedded OEM relationships, and margin expansion potential. ~75% of VGNT revenue comes from full-service programs, providing early design involvement and stickier, higher-value customer relationships than basic harness suppliers. Management targets ~12% adj. EBITDA margin by 2028 and ~$1B cumulative FCF from 2026–2028, supporting a compelling mid-teens yield.
